IMMUNOGLOBULINKLØVNINGSFRAGMENTER SOM SYGDOMS-INDIKATORER OG SAMMENSÆTNINGER TIL PÅVISNING OG BINDING AF SÅDANNE

摘要

The invention relates to antibody compositions and use of the composition to detect disease processes associated with elaboration of proteases. The reagents are directed to assessing an IgG breakdown product that is the result of such proteolytic cleavage. The invention further relates to the use of a therapeutic immunospecific for IgG breakdown products retaining antigen binding but having lost effector functions.